Susan

Make a Difference Today by Registering for the 2023 Susan G. Komen 3-Day Series

Retrieved on: 
Thursday, March 23, 2023
Susan G. Komen 3-Day for the Cure, Komen, Research, Bank of America, Walking, Susan, City, Bank, Health, Event, Breast cancer, Disease, Birth control, Series

Susan G. Komen is excited to announce the return of the 3-Day, a 60-mile walk for people committed to end breast cancer.

Key Points: 
  • Susan G. Komen is excited to announce the return of the 3-Day, a 60-mile walk for people committed to end breast cancer.
  • "The Susan G. Komen 3-Day is a powerful opportunity to join a community of individuals committed to making a difference in the fight against breast cancer," said Paula Schneider, CEO of Susan G. Komen.
  • "We encourage everyone to take on this challenge and join us for the 2023 3-Day series in cities nationwide.
  • Susan G. Komen has led the fight to create a world without breast cancer for 40 years.

Introduction of Diagnostic and Supplemental Imaging Legislation Would Benefit Thousands of Nevadans

Retrieved on: 
Wednesday, March 22, 2023
Nevada Cancer Institute, Partnership, Legislation, COVID-19, Survival, Breast, Breast MRI, Google Images, MRI, Patient, Susan, Breast cancer, Death, Biopsy, Disease, Medical imaging, Policy

CARSON CITY, Nev., March 22, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Senator Roberta Lange (D-Las Vegas) for working with Komen and the Nevada Cancer Coalition to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 2,620 people will be diagnosed with breast cancer and more than 440 will die of the disease in Nevada alone.

Key Points: 
  • "This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests," said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
  • SB 330 , introduced by Sen. Lange, would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary.
  • An estimated 16 percent of people who receive annual screening mammograms nationwide get called back for diagnostic imaging.
  • More diagnostic and supplemental breast imaging is likely going to be needed due to "missed" breast cancers during the COVID-19 pandemic.

Covant Therapeutics Announces the Formation of its Scientific Advisory Board to Support Platform and Pipeline Advancement

Retrieved on: 
Tuesday, March 7, 2023
Royal, National academy, DNA, Alvan, Harvard Medical School, Science, Merck, Dana–Farber Cancer Institute, JANUVIA, Chromosome, Roivant Sciences, DNA repair, Institute of technology, Cell, Therapy, Technical University of Munich, Schering-Plough, Drug discovery, Human Proteome Organization, Proteomics, University, Research, Analytical and Bioanalytical Chemistry, Radiation therapy, UCB, FRSC, Cancer, Royal Society, SAB, Susan, AbbVie, United States Air Force Scientific Advisory Board, Patient, GSK, National Academy of Medicine, British Mass Spectrometry Society, The German, Pharmaceutical industry, Chemistry, Medicine

BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company incubated by Roivant Sciences (Nasdaq: ROIV), today announced the formation of its Scientific Advisory Board (SAB).

Key Points: 
  • BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company incubated by Roivant Sciences (Nasdaq: ROIV), today announced the formation of its Scientific Advisory Board (SAB).
  • Covant uses its unprecedented high-throughput chemoproteomics platform to discover novel small molecule therapeutics against hard-to-drug immunology and oncology targets.
  • “This is a very exciting time for Covant as we continue to build our compelling pipeline of therapeutic programs,” said Dr. Ivan Cornella, Chief Scientific Officer of Covant.
  • “I am thrilled to welcome our new Scientific Advisory Board members.

Introduction of Diagnostic and Supplemental Imaging Legislation Would Benefit Thousands of Wisconsinites

Retrieved on: 
Thursday, February 23, 2023
Death, Nate Gustafson, Disease, Legislation, Breast cancer, Biopsy, MRI, Woman, Susan, Breast, COVID-19, Breast MRI, Patient, Google Images, Komen, Medical imaging, Policy

MADISON, Wis., Feb. 23, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Senator Rachael Cabral-Guevara (R-Appleton) and Representative Nate Gustafson (R-Neenah) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 5,460 people will be diagnosed with breast cancer and more than 720 will die of the disease in Wisconsin alone.

Key Points: 
  • "This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests," said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
  • The bills introduced by Sen. Cabral-Guevara and Rep. Gustafson would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary.
  • An estimated 16 percent of people who receive annual screening mammograms nationwide get called back for diagnostic imaging.
  • More diagnostic and supplemental breast imaging is likely going to be needed due to "missed" breast cancers during the COVID-19 pandemic.

Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Kentuckians

Retrieved on: 
Wednesday, February 22, 2023
Death, Disease, Legislation, Breast cancer, Biopsy, MRI, HB, News, Susan, Breast, COVID-19, Breast MRI, Patient, Google Images, Medical imaging, Policy

FRANKFORT, Ky., Feb. 22, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Representative Lisa Willner (D-Louisville) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 4,030 people will be diagnosed with breast cancer and more than 790 will die of the disease in Kentucky alone.

Key Points: 
  • "This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests," said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
  • HB 462 , introduced by Rep. Willner, would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary.
  • An estimated 16 percent of people who receive annual screening mammograms nationwide get called back for diagnostic imaging.
  • More diagnostic and supplemental breast imaging is likely going to be needed due to "missed" breast cancers during the COVID-19 pandemic.

Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Oregonians

Retrieved on: 
Wednesday, February 22, 2023
Death, Breast cancer, Cancer, Susan, Diagnosis, Disease, Breast MRI, Prognosis, Patient, Google Images, MRI, Legislation, Breast, Biopsy, COVID-19, Medical imaging, Policy

SALEM, Ore., Feb. 22, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Senator Kate Lieber (D-Beaverton) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 4,220 people will be diagnosed with breast cancer and more than 570 will die of the disease in Oregon alone.

Key Points: 
  • "This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests," said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
  • SB 1041 , introduced by Sen. Lieber, would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary.
  • An estimated 16 percent of people who receive annual screening mammograms nationwide get called back for diagnostic imaging.
  • More diagnostic and supplemental breast imaging is likely going to be needed due to "missed" breast cancers during the COVID-19 pandemic.

Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Montanans

Retrieved on: 
Wednesday, February 22, 2023
Death, Disease, Legislation, Breast cancer, Biopsy, MRI, HB, Susan, Breast, Diagnosis, COVID-19, Breast MRI, Patient, Google Images, Medical imaging, Policy

HELENA, Mont., Feb. 22, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Representative Jodee Etchart (R-Billings) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 1,030 people will be diagnosed with breast cancer and more than 150 will die of the disease in Montana alone.

Key Points: 
  • "This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests," said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
  • HB 665 , introduced by Rep. Etchart, would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary.
  • "This legislation does just that and will encourage additional imaging, when indicated, to ensure early diagnosis and subsequent treatment that benefits all Montanans."
  • More diagnostic and supplemental breast imaging is likely going to be needed due to "missed" breast cancers during the COVID-19 pandemic.

Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Kansans

Retrieved on: 
Monday, February 20, 2023
Human services, Susan, Google Images, Legislation, Breast cancer, MRI, Patient, House Committee, Survivor, Biopsy, Death, Disease, Komen, Breast, COVID-19, Breast MRI, HB, Medical imaging, Health, Policy

TOPEKA, Kan., Feb. 20, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Senator Dinah Sykes (D-Lenexa) and the House Committee on Health and Human Services for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 2,470 people will be diagnosed with breast cancer and more than 370 will die of the disease in Kansas alone.

Key Points: 
  • "This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests," said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
  • SB 161 , introduced by Sen. Sykes, and HB 2287 would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary.
  • An estimated 16 percent of people who receive annual screening mammograms nationwide get called back for diagnostic imaging.
  • More diagnostic and supplemental breast imaging is likely going to be needed due to "missed" breast cancers during the COVID-19 pandemic.

Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Tennesseans

Retrieved on: 
Monday, February 20, 2023
Woman, Susan, Google Images, Legislation, Diagnosis, Breast cancer, MRI, Patient, Mortality, Biopsy, Death, Disease, Breast, COVID-19, Breast MRI, HB, Medical device, Medical imaging, Policy

NASHVILLE, Tenn., Feb. 20, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Senator Becky Massey (R-Knoxville) and Representative Rebecca Alexander (D-Jonesborough) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 6,210 people will be diagnosed with breast cancer and more than 1,030 will die of the disease in Tennessee alone.

Key Points: 
  • "This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests," said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
  • SB 365 , introduced by Sen. Massey and HB 355 , introduced by Rep. Alexander, would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary.
  • "This legislation will eliminate burdensome barriers for patients requiring these vital breasts imaging services, allowing for a more timely diagnosis."
  • More diagnostic and supplemental breast imaging is likely going to be needed due to "missed" breast cancers during the COVID-19 pandemic.

Dr. Samuel Lin Continues Partnership With Haute Beauty Network

Retrieved on: 
Friday, February 17, 2023
American Academy of Facial Plastic and Reconstructive Surgery, Science, Rhinoplasty, Physician, Editorial board, Susan, Expert, Plastic surgery, MD Anderson Cancer Center, Honors colleges and programs, Northwestern Memorial Hospital, Pearl, Bachelor, Northwestern University, Biomedicine, Literature, Medical education, Division, Harvard University, ABMS, Harvard Medical School, Biomedical engineering, Certification, Breast surgery, University, Elective surgery, Medical specialty, University of Texas at Austin, Editor-in-chief, Student, Associate, American Board of Commissioners for Foreign Missions, Knowledge, Partnership, Plastic and Reconstructive Surgery, AAPS, Feinberg School of Medicine, Cure, Internet celebrity, Dentistry, Head, Plastic

BOSTON, Feb. 17, 2023 /PRNewswire-PRWeb/ -- Dr. Samuel Lin is a double board-certified Plastic Surgeon and Associate Professor of Surgery at Harvard Medical School who practices in Boston, Massachusetts. Dr. Lin received his Bachelor's degree in Biomedical Engineering at Northwestern University and was enrolled in the Honors Program for Medical Education at Northwestern University, Feinberg School of Medicine, Chicago, Illinois. He then completed a five-year residency in Otolaryngology-Head and Neck Surgery followed by a three-year residency in Plastic and Reconstructive Surgery at Northwestern Memorial Hospital. This was followed by a one-year fellowship appointment in Microvascular Reconstructive Surgery at the world-renowned University of Texas M.D. Anderson Cancer Center in Houston, Texas. Throughout the course of his training, Dr. Lin gained state-of-the-art skills in a multitude of reconstructive and cosmetic procedures with his background in Head and Neck Surgery providing him with additional expertise in Plastic and Reconstructive Surgery. He has also been named a Top Influencer in #PlasticSurgery.

Key Points: 
  • Nose Expert from Boston, Dr. Samuel Lin, continues his partnership with Haute Beauty Network, now in his fifth year.
  • BOSTON, Feb. 17, 2023 /PRNewswire-PRWeb/ -- Dr. Samuel Lin is a double board-certified Plastic Surgeon and Associate Professor of Surgery at Harvard Medical School who practices in Boston, Massachusetts.
  • This was followed by a one-year fellowship appointment in Microvascular Reconstructive Surgery at the world-renowned University of Texas M.D.
  • Dr. Lin is board certified by both the American Board of Plastic Surgery and the American Board of Otolaryngology-Head and Neck Surgery.